Cargando…

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity

BACKGROUND: The development of pathological cardiac hypertrophy involves the coordination of a series of transcription activators and repressors, while their interplay to trigger pathological gene reprogramming remains unclear. NULP1 (nuclear localized protein 1) is a member of the basic helix‐loop‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xin, Lei, Fang, Wang, Xiao‐Ming, Deng, Ke‐Qiong, Ji, Yan‐Xiao, Zhang, Yan, Li, Hongliang, Zhang, Xiao‐Dong, Lu, Zhibing, Zhang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660797/ https://www.ncbi.nlm.nih.gov/pubmed/32805187 http://dx.doi.org/10.1161/JAHA.120.016419

Ejemplares similares

How does NFAT3 regulate the occurrence of cardiac hypertrophy?
por: Hui, Wang, et al.
Publicado: (2023)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
por: Ji, Yan-Xiao, et al.
Publicado: (2016)

Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway
por: Li, Xiurong, et al.
Publicado: (2017)

A NFAT decoy approach to inhibit cardiac hypertrophy
por: Heineke, Joerg
Publicado: (2021)

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2023)

Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin/NFAT2 pathway
por: Xiao, Lili, et al.
Publicado: (2017)

The bHLH Protein Nulp1 is Essential for Femur Development Via Acting as a Cofactor in Wnt Signaling in Drosophila
por: Zeng, Q., et al.
Publicado: (2017)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy
por: Wang, Zhihua, et al.
Publicado: (2016)

Transcriptional Regulation of TMP21 by NFAT
por: Liu, Shengchun, et al.
Publicado: (2011)

GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy
por: Duran, Javier, et al.
Publicado: (2016)

Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling
por: Verma, Nirmal, et al.
Publicado: (2021)

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
por: Zhou, Heng, et al.
Publicado: (2011)

AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
por: Remes, Anca, et al.
Publicado: (2021)

Mechanistic analysis of resveratrol in cardiac hypertrophy by network pharmacology and animal experiments
por: Ren, Shan, et al.
Publicado: (2022)

Myotubularin-related protein 14 suppresses cardiac hypertrophy by inhibiting Akt
por: Zhang, Jie-Lei, et al.
Publicado: (2020)

Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy
por: Chang, Tzu-Hao, et al.
Publicado: (2016)

Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity
por: Loyer, Xavier, et al.
Publicado: (2019)

Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy
por: Gao, Maomao, et al.
Publicado: (2020)

CD38 promotes angiotensin II‐induced cardiac hypertrophy
por: Guan, Xiao‐Hui, et al.
Publicado: (2017)

Gastrodin Inhibits Store-Operated Ca(2+) Entry and Alleviates Cardiac Hypertrophy
por: Zheng, Changbo, et al.
Publicado: (2017)

The Involvement of NFAT Transcriptional Activity Suppression in SIRT1-Mediated Inhibition of COX-2 Expression Induced by PMA/Ionomycin
por: Jia, Yu-Yan, et al.
Publicado: (2014)

Deciphering transcriptional dynamics of cardiac hypertrophy and failure in a chamber-specific manner
por: Zhang, Dan, et al.
Publicado: (2023)

Requirement of transcription factor NFAT in developing atrial myocardium
por: Schubert, William, et al.
Publicado: (2003)

Tripartite motif 32 prevents pathological cardiac hypertrophy
por: Chen, Lijuan, et al.
Publicado: (2016)

Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy
por: Luo, Yuxuan, et al.
Publicado: (2021)

Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy
por: Lunde, Ida G., et al.
Publicado: (2022)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

The cardiac calsequestrin gene transcription is modulated at the promoter by NFAT and MEF-2 transcription factors
por: Estrada-Avilés, Rafael, et al.
Publicado: (2017)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

I(K1) Channel Agonist Zacopride Alleviates Cardiac Hypertrophy and Failure via Alterations in Calcium Dyshomeostasis and Electrical Remodeling in Rats
por: Liu, Qing-Hua, et al.
Publicado: (2019)

NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription()()
por: Zhang, Jian, et al.
Publicado: (2019)

Suppression of calcium-sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy
por: LIU, LEI, et al.
Publicado: (2016)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

ndufa7 plays a critical role in cardiac hypertrophy
por: Shi, Xingjuan, et al.
Publicado: (2020)

Carboxyl‐Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway
por: Liu, Xiaoxiong, et al.
Publicado: (2018)

Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway
por: Liao, Hai-han, et al.
Publicado: (2019)

Mycoplasma genitalium Protein of Adhesion Suppresses T Cell Activation via CypA-CaN-NFAT Pathway
por: Luo, Dan, et al.
Publicado: (2023)

TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway
por: Li, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_djmomtc98vg6gv5755cai79sv4